Guerbet
25.30
23-December-24 08:23:10
15 minutes delayed
Stocks
+0.20
+0.80%
Today's range
25.05 - 25.30
ISIN
FR0000032526
Source
Cboe
-
GUERBET : Financial agenda for 2025
31 Oct 2024 13:00:00 By Nasdaq GlobeNewswire
-
GUERBET : Revenue at September 30, 2024.
24 Oct 2024 11:45:00 By Nasdaq GlobeNewswire
-
25 Sep 2024 11:45:00 By Nasdaq GlobeNewswire
-
25 Jul 2024 11:45:00 By Nasdaq GlobeNewswire
-
Guerbet : Hugues Lecat appointed Chairman of the Board of Directors of Guerbet.
24 May 2024 11:44:58 By Nasdaq GlobeNewswire
-
22 May 2024 11:45:00 By Nasdaq GlobeNewswire
-
25 Apr 2024 11:45:00 By Nasdaq GlobeNewswire
-
Guerbet: Financial agenda for 2024
15 Jan 2024 12:00:00 By Nasdaq GlobeNewswire
-
GUERBET : Revenue at 30 September 2023.
19 Oct 2023 11:45:00 By Nasdaq GlobeNewswire
-
Guerbet: CHMP positive opinion
12 Oct 2023 11:57:24 By Nasdaq GlobeNewswire
-
Guerbet: 2023 half-year results
20 Sep 2023 11:45:00 By Nasdaq GlobeNewswire
-
Guerbet: First-half 2023 revenue
20 Jul 2023 11:46:36 By Nasdaq GlobeNewswire
-
Guerbet: Guerbet wins PI-CAI Grand Challenge on detection of prostate cancer
17 Jul 2023 13:00:19 By Nasdaq GlobeNewswire
-
10 Jul 2023 11:48:16 By Nasdaq GlobeNewswire
-
Guerbet: Changes in Guerbet's Board of Directors
26 May 2023 11:29:04 By Nasdaq GlobeNewswire
-
20 Apr 2023 11:49:25 By Nasdaq GlobeNewswire
-
22 Mar 2023 12:45:58 By Nasdaq GlobeNewswire
-
09 Feb 2023 11:46:34 By Nasdaq GlobeNewswire
-
Guerbet: 2023 Strategic Priorities
16 Jan 2023 12:40:42 By Nasdaq GlobeNewswire
-
11 Jan 2023 13:46:47 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >